The FDA Medline bed alert, posted on 29 October 2026, covers all Medline-brand beds and associated components after the manufacturer reported two deaths and 16 serious injuries as of 20 October. The agency published it as an early alert about a potentially high-risk device issue. The hazards include electrical overheating that can cause smoking, sparking, melting and fire, and entrapment or asphyxiation risks linked to accessories. Medline has also announced that it is discontinuing and exiting the bed market. This article explains what the alert says, what owners and care facilities are told to do, and where the sources disagree.
FDA Medline bed alert: key takeaways
- The alert covers all Medline-brand beds and associated products, including homecare and long-term-care beds, pendants, accessories and parts.
- As of 20 October 2026, Medline had reported two deaths and 16 serious injuries.
- Medline has told customers it is removing the beds from sale and exiting the bed market; an initial announcement was made on 14 October.
- Some beds may stay in use if updated instructions are followed, and Medline is offering repair where possible.
- Reports differ on whether beds that cannot be repaired qualify for a full or a partial refund.
What the FDA Medline bed alert says about the hazards
According to press accounts of the alert, using extension cords, or non-Medline or unapproved pendants and accessories, can cause a bed’s electrical components to overheat, with smoking, sparking, melting, burning or fire as possible results. A separate hazard involves accessories that may trap a patient, creating entrapment and asphyxiation risk. The FDA said it is currently reviewing information about this potentially high-risk device issue. FDA device alerts are collected on the FDA recalls and early alerts page.
Which beds are covered by the FDA Medline bed alert
The scope is broad: all Medline-brand beds and associated components. Coverage of the alert describes beds for home and long-term care, including bariatric models, and accessories such as pendants, side rails, mattresses and replacement parts. The sources we reviewed do not say how many units are in use. Owners and facilities should check model information against Medline’s notice and not rely on our summary to identify a specific bed.
What owners are told to do after the FDA Medline bed alert
Reports say current owners may keep using affected beds if they follow Medline’s updated instructions: plug the bed in only when needed to reposition the patient and do not use extension cords. Medline is offering repairs where possible, and a replacement or refund where it is not. Customers can reach Medline’s recall line at 1-800-950-0128 (option 7), according to one report, and adverse events such as fires can be reported to the FDA through MedWatch. An updated customer notice dated 24 October was mentioned in the information we were given, but we could not confirm that date in the sources we reviewed.
Where reports differ on the FDA Medline bed alert
The sources disagree on one point. One report says beds that cannot be repaired are eligible for a replacement or a partial refund of the original purchase price. Another says a full refund or replacement. We cannot resolve this from the material we have, so affected customers should confirm the terms directly with Medline. Medline said it recognises the impact the decision may have on the healthcare system.
Why the FDA Medline bed alert matters for care settings
Beds are used continuously, often by people who cannot move easily, so a failure can have severe consequences. Facilities that rely on Medline beds may need to plan repair, replacement and staff instructions at the same time. The alert is directed at hospitals, long-term-care providers, distributors and families using beds at home. Related reports are in our Medical Device coverage.
Market context from Acumen Research and Consulting
Acumen Research and Consulting’s Hospital Beds Market report values the global market at USD 3.6 billion in 2022 and projects USD 7.2 billion by 2032, a CAGR of 7.2% for 2023 to 2032. It says powered beds held about 58% in 2022 and long-term care generated about USD 1.8 billion. The page was last updated in March 2023 and is inconsistent about the fastest-growing region, so the figures are dated estimates and do not describe Medline’s share.
Timeline of the FDA Medline bed alert
- 14 October 2026: Medline announces removal, discontinuation and market exit.
- 20 October 2026: cut-off date for the reported two deaths and 16 serious injuries.
- 29 October 2026: FDA early alert posted.
General background: why bed safety is regulated
Powered beds contain motors, wiring and hand controls, and add-on accessories can change how they behave. Standards and FDA guidance exist to reduce entrapment and electrical risks, and manufacturers must report serious injuries and deaths.
Our analysis of the FDA Medline bed alert
In our assessment, the FDA Medline bed alert is significant because it combines serious reported harm, a very broad product scope and a manufacturer exit from the category. The practical priority for users is following the updated instructions and arranging repair or replacement.
What is not disclosed about the FDA Medline bed alert
- Number of beds in use and affected.
- Final FDA classification.
- Details of the incidents and the settings in which they occurred.
Risks and caveats
This article summarises press accounts of the alert and does not replace the FDA or Medline notices. It is news reporting and not safety or legal advice.
What to watch next after the FDA Medline bed alert
- Any update to the FDA alert or classification.
- Medline repair and replacement progress.
- Guidance for facilities on transition.
FAQ
What did the FDA announce?
An early alert about all Medline-brand beds and associated products.
Can the beds still be used?
Reports say some can, if updated instructions are followed.
How many people were harmed?
Two deaths and 16 serious injuries as of 20 October 2026.
How we reported this: we relied on press accounts of the FDA early alert, FDA public pages and the Acumen Research and Consulting report cited above. Last updated 30 October 2026. This is news reporting and not advice.